Bexion Pharmaceuticals launches phase 1 part 3 trial of cancer drug BXQ-350
US pharma company Bexion Pharmaceuticals has launched part 3 of their phase 1 human trial for BXQ-350 for cancer treatment.
Continue readingCoverage of Global Pharma Industry News
US pharma company Bexion Pharmaceuticals has launched part 3 of their phase 1 human trial for BXQ-350 for cancer treatment.
Continue readingAlexion Pharmaceuticals has bagged FDA priority review for the use of its C5 complement inhibitor SOLIRIS (eculizumab) as a treatment
Continue readingConnecticut-based biopharma company Biohaven Pharmaceutical has secured orphan drug designation from the US FDA for its myeloperoxidase (MPO) inhibitor verdiperstat
Continue readingChinese pharma companies Innovent Biologics and Shenzhen Chipscreen Biosciences have agreed to evaluate their respective drugs as combination therapy in
Continue readingOT-58 clinical trial news : Swiss pharma company Orphan Technologies has dosed the first patients in a phase 1/2 trial,
Continue readingGerman pharma company Merck will invest $70 million for the expansion of its US and Canada biopharma business EMD Serono’s
Continue readingGerman pharma company Fresenius Kabi has launched Methocarbamol Injection, USP in the US in a 100 mg per mL 10
Continue readingClinical trial news : Novus Therapeutics has initiated a phase 1 pharmacodynamics clinical trial of its lead candidate OP0201 for
Continue readingADCETRIS EC approval : The European Commission (EC) has expanded the approval of Takeda Pharmaceutical’s ADCETRIS (brentuximab vedotin) to cover
Continue readingDr.Henry’s Vitamins has revealed their latest products, the Prenatal Plus and Omega-3 for Women, which are claimed to be made
Continue reading